Endocrinology, Vol 137, 1764-1774, Copyright © 1996 by Endocrine Society

ARTICLES

Proliferation and differentiation of a human colon cancer cell line (CaCo2) is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF) IGF-II and IGF binding protein-4: role of IGF-II

P Singh, B Dai, U Yallampalli, X Lu and PC Schroy
Department of Anatomy and Neurosciences, University of Texas Medical Branch, Galveston 77555-1043, USA. psingh@mbian.utmb.edu

The extent to which the insulin-like growth factor (IGF) system contributes to the initiation and progression of colon cancer remains poorly defined. We recently reported that a majority of human colon cancers express and secrete the potent mitogen IGF-II and at least two inhibitory binding proteins, IGFBP-2 and IGFBP-4. In the present study we measured the expression and secretion of IGF-II, IGFBP-2, and IGFBP- 4 in relation to growth and differentiation of CaCo2 human colon cancer cells, which undergo spontaneous enterocytic differentiation in culture. Under the conditions of the present study, CaCo2 cells demonstrated an initial rapid phase of growth between Day 2 through days 7-9 of culture, followed by a significant retardation in the growth between days 9-13. Alkaline phosphatase (ALP) activity, a marker of enterocytic differentiation, progressively increased between Days 7- 13 in culture, temporally correlating with post-confluent phase of negligible growth. These changes in growth and differentiation were accompanied by > 80% decline in the relative concentration of IGF-II messenger RNA (mRNA) between Days 2-13. In contrast, the relative mRNA concentrations of inhibitory binding proteins (IGFBP-2 and IGFBP-4) increased rapidly to 200% of Day 2 values by Days 5-7 before returning to baseline levels by Day 13. The relative protein concentrations of the three factors measured in the conditioned media of the cells followed a pattern very similar to that measured for the mRNA levels. While the changes in the relative protein concentrations and mRNA levels of IGF-II and IGFBP-4 were statistically significant, the changes measured in the RNA and protein levels of IGFBP-2 were not, as a result of large inter experimental variations. Thus these results suggested that CaCo2 cell differentiation may require an attenuation of IGF-II effects. To confirm the latter possibility, additional studies were conducted with a specific neutralizing antibody against IGF-II. Incubation of CaCo2 cells with anti-IGF-II antibodies from Day 0 through Day 7 significantly retarded the growth of the cells and was accompanied by a significant increase in the concentration of Alkaline phosphatase activity per 10(6) cells. Recently, we reported a potent inhibitory role of IGFBP-4 in the growth of colon cancer cells. In the present studies, a possible important role of IGF-II is illustrated not only in the growth but also in the differentiation of colonic cells. Our studies thus suggest that differential expression of IGF-II and IGFBPs may be playing a critical role in both proliferation and differentiation of colonocytes.

This article has been cited by other articles:

				K. F. Foley, C. Pantano, A. Ciolino, and G. M. Mawe IFN-{gamma} and TNF-{alpha} decrease serotonin transporter function and expression in Caco2 cells Am J Physiol Gastrointest Liver Physiol, March 1, 2007; 292(3): G779 - G784. [Abstract] [Full Text] [PDF]

				S. D. Hursting, J. A. Lavigne, D. Berrigan, L. A. Donehower, B. J. Davis, J. M. Phang, J. C. Barrett, and S. N. Perkins Diet-Gene Interactions in p53-Deficient Mice: Insulin-like Growth Factor-1 as a Mechanistic Target J. Nutr., September 1, 2004; 134(9): 2482S - 2486S. [Abstract] [Full Text] [PDF]

				B. L. Dake, M. Boes, L. A. Bach, and R. S. Bar Effect of an Insulin-Like Growth Factor Binding Protein Fusion Protein on Thymidine Incorporation in Neuroblastoma and Rhabdomyosarcoma Cell Lines Endocrinology, July 1, 2004; 145(7): 3369 - 3374. [Abstract] [Full Text] [PDF]

				K. J. Hunt, P. Toniolo, A. Akhmedkhanov, A. Lukanova, H. Dechaud, S. Rinaldi, A. Zeleniuch-Jacquotte, R. E. Shore, E. Riboli, and R. Kaaks Insulin-like Growth Factor II and Colorectal Cancer Risk in Women Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 901 - 905. [Abstract] [Full Text] [PDF]

				A. Hoeflich, R. Reisinger, H. Lahm, W. Kiess, W. F. Blum, H. J. Kolb, M. M. Weber, and E. Wolf Insulin-like Growth Factor-binding Protein 2 in Tumorigenesis: Protector or Promoter? Cancer Res., December 1, 2001; 61(24): 8601 - 8610. [Full Text] [PDF]

				S. Kermorgant, V. Dessirier, M. J. M. Lewin, and T. Lehy HGF upregulates and modifies subcellular distribution of proteins in colon cancer cell enterocytic differentiation Am J Physiol Gastrointest Liver Physiol, October 1, 2001; 281(4): G1068 - G1080. [Abstract] [Full Text] [PDF]

				S. L. Leng, K. S. Leeding, P. R. Gibson, and L. A. Bach Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo Carcinogenesis, October 1, 2001; 22(10): 1625 - 1631. [Abstract] [Full Text] [PDF]

				E. L. van Dijk, J. S. Sussenbach, and P. E. Holthuizen Kinetics and regulation of site-specific endonucleolytic cleavage of human IGF-II mRNAs Nucleic Acids Res., September 1, 2001; 29(17): 3477 - 3486. [Abstract] [Full Text] [PDF]

				H. Yu and T. Rohan Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression J Natl Cancer Inst, September 20, 2000; 92(18): 1472 - 1489. [Abstract] [Full Text] [PDF]

				A. G. Renehan, J. E. Painter, D. O’Halloran, W. S. Atkin, C. S. Potten, S. T. O’Dwyer, and S. M. Shalet Circulating Insulin-Like Growth Factor II and Colorectal Adenomas J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3402 - 3408. [Abstract] [Full Text]

				C. Qin, P. Singh, and S. Safe Transcriptional Activation of Insulin-Like Growth Factor-Binding Protein-4 by 17{beta}-Estradiol in MCF-7 Cells: Role of Estrogen Receptor-Sp1 Complexes Endocrinology, June 1, 1999; 140(6): 2501 - 2508. [Abstract] [Full Text]

				S Freier, O Weiss, M Eran, A Flyvbjerg, R Dahan, I Nephesh, T Safra, E Shiloni, and I Raz Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon Gut, May 1, 1999; 44(5): 704 - 708. [Abstract] [Full Text] [PDF]

				J. Ma, M. N. Pollak, E. Giovannucci, J. M. Chan, Y. Tao, C. H. Hennekens, and M. J. Stampfer Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF-Binding Protein-3 J Natl Cancer Inst, April 7, 1999; 91(7): 620 - 625. [Abstract] [Full Text] [PDF]

				C. Duan and D. R. Clemmons Differential Expression and Biological Effects of Insulin-like Growth Factor-binding Protein-4 and -5 in Vascular Smooth Muscle Cells J. Biol. Chem., July 3, 1998; 273(27): 16836 - 16842. [Abstract] [Full Text] [PDF]

				F. L. Garrouste, M. M. Remacle-Bonnet, M. M.-A. Lehmann, J. L. Marvaldi, and G. J. Pommier Up-Regulation of Insulin/Insulin-Like Growth Factor-I Hybrid Receptors during Differentiation of HT29-D4 Human Colonic Carcinoma Cells Endocrinology, May 1, 1997; 138(5): 2021 - 2032. [Abstract] [Full Text] [PDF]

				B. Dai, S. G. Widen, R. Mifflin, and P. Singh Cloning of the Functional Promoter for Human Insulin-Like Growth Factor Binding Protein-4 Gene: Endogenous Regulation Endocrinology, January 1, 1997; 138(1): 332 - 343. [Abstract] [Full Text] [PDF]

				B. Dai, H. Wu, E. Holthuizen, and P. Singh Identification of a Novel Cis Element Required for Cell Density-dependent Down-regulation of Insulin-like Growth Factor-2 P3 Promoter Activity in CaCo2 Cells J. Biol. Chem., March 2, 2001; 276(10): 6937 - 6944. [Abstract] [Full Text] [PDF]